SCHEMBL31589151

SCHEMBL31589151

O=C1CC[C@@H](N2C(=O)c3cc(F)c(F)cc3C2=O)C(=O)N1

nearest known ligand 0.74

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.74
▸ DDB1 Q16531 11/20 0.74
▸ IKZF3 Q9UKT9 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ CHRM2 P08172 1/20 0.69
▸ OPRM1 P35372 1/20 0.69
▸ CYP1A2 P05177 1/20 0.69
▸ TSHR P16473 1/20 0.69
▸ TDP1 Q9NUW8 1/20 0.69
▸ TNF P01375 2/20 0.63
▸ IL1B P01584 1/20 0.57
▸ TBXA2R P21731 1/20 0.57
▸ IKZF1 Q13422 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20046349 1.00 CRBN (0.74) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL31589475 1.00 CRBN (0.74) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL26708871 0.91 CRBN (0.67) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20128940 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22737184 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24474319 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL31586304 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22566233 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24938184 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22737356 0.90 CRBN (0.66) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025108404-A1 HETEROCYCLIC COMPOUND OF BIFUNCTIONAL CHIMERA FOR TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND USE THEREOF 广东东阳光药业股份有限公司 2025-05-30 — — WO disclosed
CN-120025326-A Heterocyclic compound of bifunctional chimera for targeting and degrading androgen receptor and application thereof 广东东阳光药业股份有限公司 2025-05-23 — — CN disclosed
Send feedback